Written by Richard Simmons| Thursday, 12 May 2011| There are 0 comments
Pfizer has received full approval for Revatio by the EMEA of the European Union to treat children between the age of 1 and 17. The drug which is identical to Viagra has routinely been used and is already approved for use with adult patients with pulmonary arterial hypertension. Dr. Cara Cassino speaking on behalf of the Pfizer Medicines Development Group described pulmonary arterial hypertension as a rare and devastating disease.

While it was immediately obvious that Revatio could help children suffering from pulmonary arterial hypertension, it was necessary to get the correct approvals and also to conduct safety testing before it could be routinely prescribed for them. It is however likely that hundreds of children suffering from this extremely rare condition already use either Revatio or Viagra to alleviate their symptoms.
Ukmedix News has reported on many cases where children or even newborn babies were given tiny doses of Viagra to help them to absorb oxygen and ultimately to save their lives. Whether the medicine was legally prescribed or not was of little concern to both the doctors and parents of the young children because they were often facing a life or death scenario.
The recent testing however done with the active ingredient of both Viagra and Revatio namely Sildenafil citrate was useful and important because it adds mass to the evidence that it is both safe and effective to give to children and adults.
The number of people suffering from pulmonary arterial hypertension is minuscule compared to the amount of men suffering from impotence, nevertheless Pfizer said that they wanted to show that they were not just out to make profits and that they wanted to help with the development of medicines for rare diseases as well as the more common ones.
Revatio for children will be made available in a number of different ways including in oral and I.V. formulas.
